nodes	percent_of_prediction	percent_of_DWPC	metapath
Liotrix—TTR—choroid plexus—malignant glioma	0.0754	0.167	CbGeAlD
Liotrix—SERPINA7—vertebral column—malignant glioma	0.0581	0.129	CbGeAlD
Liotrix—SLC22A8—choroid plexus—malignant glioma	0.0462	0.103	CbGeAlD
Liotrix—TTR—vertebral column—malignant glioma	0.0267	0.0592	CbGeAlD
Liotrix—TTR—pineal body—malignant glioma	0.0192	0.0426	CbGeAlD
Liotrix—Infertility—Carmustine—malignant glioma	0.0179	0.0735	CcSEcCtD
Liotrix—Infertility—Temozolomide—malignant glioma	0.0173	0.071	CcSEcCtD
Liotrix—Clotting—Temozolomide—malignant glioma	0.0126	0.0519	CcSEcCtD
Liotrix—SERPINA7—spinal cord—malignant glioma	0.0081	0.018	CbGeAlD
Liotrix—THRB—brainstem—malignant glioma	0.00805	0.0179	CbGeAlD
Liotrix—THRA—brainstem—malignant glioma	0.00805	0.0179	CbGeAlD
Liotrix—THRA—telencephalon—malignant glioma	0.00714	0.0158	CbGeAlD
Liotrix—SERPINA7—central nervous system—malignant glioma	0.00657	0.0146	CbGeAlD
Liotrix—TTR—embryo—malignant glioma	0.00653	0.0145	CbGeAlD
Liotrix—SERPINA7—cerebellum—malignant glioma	0.00642	0.0143	CbGeAlD
Liotrix—TTR—brainstem—malignant glioma	0.00598	0.0133	CbGeAlD
Liotrix—Necrosis—Carmustine—malignant glioma	0.00594	0.0244	CcSEcCtD
Liotrix—SLCO1C1—telencephalon—malignant glioma	0.00594	0.0132	CbGeAlD
Liotrix—Abscess—Carmustine—malignant glioma	0.0059	0.0242	CcSEcCtD
Liotrix—Coagulopathy—Temozolomide—malignant glioma	0.00579	0.0238	CcSEcCtD
Liotrix—TTR—retina—malignant glioma	0.00577	0.0128	CbGeAlD
Liotrix—Extravasation—Carmustine—malignant glioma	0.00535	0.022	CcSEcCtD
Liotrix—TTR—telencephalon—malignant glioma	0.00531	0.0118	CbGeAlD
Liotrix—SLCO4A1—retina—malignant glioma	0.00517	0.0115	CbGeAlD
Liotrix—SLC16A2—medulla oblongata—malignant glioma	0.00508	0.0113	CbGeAlD
Liotrix—THRA—spinal cord—malignant glioma	0.005	0.0111	CbGeAlD
Liotrix—SLCO4A1—telencephalon—malignant glioma	0.00476	0.0106	CbGeAlD
Liotrix—SLC16A2—spinal cord—malignant glioma	0.00453	0.0101	CbGeAlD
Liotrix—Coma—Carmustine—malignant glioma	0.00426	0.0175	CcSEcCtD
Liotrix—SLCO1C1—midbrain—malignant glioma	0.00426	0.00946	CbGeAlD
Liotrix—TTR—medulla oblongata—malignant glioma	0.00417	0.00925	CbGeAlD
Liotrix—SLCO1C1—spinal cord—malignant glioma	0.00416	0.00923	CbGeAlD
Liotrix—THRB—central nervous system—malignant glioma	0.00406	0.00901	CbGeAlD
Liotrix—THRA—central nervous system—malignant glioma	0.00406	0.00901	CbGeAlD
Liotrix—Sepsis—Carmustine—malignant glioma	0.00405	0.0166	CcSEcCtD
Liotrix—THRB—cerebellum—malignant glioma	0.00397	0.0088	CbGeAlD
Liotrix—THRA—cerebellum—malignant glioma	0.00397	0.0088	CbGeAlD
Liotrix—Phlebitis—Carmustine—malignant glioma	0.00393	0.0162	CcSEcCtD
Liotrix—Swelling—Carmustine—malignant glioma	0.00384	0.0158	CcSEcCtD
Liotrix—TTR—midbrain—malignant glioma	0.00381	0.00846	CbGeAlD
Liotrix—SLCO4A1—medulla oblongata—malignant glioma	0.00374	0.0083	CbGeAlD
Liotrix—TTR—spinal cord—malignant glioma	0.00372	0.00825	CbGeAlD
Liotrix—SLC16A2—central nervous system—malignant glioma	0.00368	0.00816	CbGeAlD
Liotrix—SLC16A2—cerebellum—malignant glioma	0.00359	0.00798	CbGeAlD
Liotrix—SLC10A1—central nervous system—malignant glioma	0.00359	0.00797	CbGeAlD
Liotrix—SLCO4A1—midbrain—malignant glioma	0.00342	0.00758	CbGeAlD
Liotrix—SLCO1A2—telencephalon—malignant glioma	0.00341	0.00756	CbGeAlD
Liotrix—SLCO1C1—central nervous system—malignant glioma	0.00337	0.00749	CbGeAlD
Liotrix—SLCO4A1—spinal cord—malignant glioma	0.00333	0.0074	CbGeAlD
Liotrix—THRB—brain—malignant glioma	0.00322	0.00715	CbGeAlD
Liotrix—THRA—brain—malignant glioma	0.00322	0.00715	CbGeAlD
Liotrix—Affect lability—Temozolomide—malignant glioma	0.00322	0.0132	CcSEcCtD
Liotrix—Mood swings—Temozolomide—malignant glioma	0.0031	0.0127	CcSEcCtD
Liotrix—Hypokalaemia—Carmustine—malignant glioma	0.00308	0.0127	CcSEcCtD
Liotrix—Dehydration—Temozolomide—malignant glioma	0.00304	0.0125	CcSEcCtD
Liotrix—TTR—central nervous system—malignant glioma	0.00302	0.00669	CbGeAlD
Liotrix—Muscular weakness—Carmustine—malignant glioma	0.00299	0.0123	CcSEcCtD
Liotrix—Hypokalaemia—Temozolomide—malignant glioma	0.00298	0.0122	CcSEcCtD
Liotrix—TTR—cerebellum—malignant glioma	0.00295	0.00654	CbGeAlD
Liotrix—Dysphagia—Carmustine—malignant glioma	0.00293	0.012	CcSEcCtD
Liotrix—SLC16A2—brain—malignant glioma	0.00292	0.00648	CbGeAlD
Liotrix—Muscular weakness—Temozolomide—malignant glioma	0.00289	0.0119	CcSEcCtD
Liotrix—SLC10A1—brain—malignant glioma	0.00285	0.00632	CbGeAlD
Liotrix—Abdominal distension—Temozolomide—malignant glioma	0.00285	0.0117	CcSEcCtD
Liotrix—Dysphagia—Temozolomide—malignant glioma	0.00283	0.0116	CcSEcCtD
Liotrix—Sweating increased—Temozolomide—malignant glioma	0.00276	0.0113	CcSEcCtD
Liotrix—Bronchitis—Temozolomide—malignant glioma	0.00272	0.0112	CcSEcCtD
Liotrix—SLCO4A1—central nervous system—malignant glioma	0.0027	0.006	CbGeAlD
Liotrix—SLCO1C1—brain—malignant glioma	0.00268	0.00595	CbGeAlD
Liotrix—SLCO1A2—medulla oblongata—malignant glioma	0.00268	0.00594	CbGeAlD
Liotrix—SLCO4A1—cerebellum—malignant glioma	0.00264	0.00587	CbGeAlD
Liotrix—Renal failure—Carmustine—malignant glioma	0.00257	0.0105	CcSEcCtD
Liotrix—Weight decreased—Temozolomide—malignant glioma	0.00256	0.0105	CcSEcCtD
Liotrix—SLCO1A2—midbrain—malignant glioma	0.00245	0.00543	CbGeAlD
Liotrix—TTR—brain—malignant glioma	0.00239	0.00531	CbGeAlD
Liotrix—SLCO1A2—spinal cord—malignant glioma	0.00239	0.0053	CbGeAlD
Liotrix—ABCB1—blood vessel—malignant glioma	0.00235	0.00522	CbGeAlD
Liotrix—Hypoaesthesia—Carmustine—malignant glioma	0.00233	0.00958	CcSEcCtD
Liotrix—SLC16A10—cerebellum—malignant glioma	0.00232	0.00514	CbGeAlD
Liotrix—Hypoaesthesia—Temozolomide—malignant glioma	0.00225	0.00926	CcSEcCtD
Liotrix—Flushing—Carmustine—malignant glioma	0.00217	0.00894	CcSEcCtD
Liotrix—SLCO4A1—brain—malignant glioma	0.00215	0.00476	CbGeAlD
Liotrix—Flushing—Temozolomide—malignant glioma	0.0021	0.00864	CcSEcCtD
Liotrix—Arrhythmia—Carmustine—malignant glioma	0.00209	0.0086	CcSEcCtD
Liotrix—Alopecia—Carmustine—malignant glioma	0.00207	0.00851	CcSEcCtD
Liotrix—Alopecia—Temozolomide—malignant glioma	0.002	0.00822	CcSEcCtD
Liotrix—SLCO1A2—central nervous system—malignant glioma	0.00194	0.0043	CbGeAlD
Liotrix—Dysgeusia—Temozolomide—malignant glioma	0.00193	0.00793	CcSEcCtD
Liotrix—Vision blurred—Carmustine—malignant glioma	0.00192	0.0079	CcSEcCtD
Liotrix—Tremor—Carmustine—malignant glioma	0.00191	0.00785	CcSEcCtD
Liotrix—SLCO1A2—cerebellum—malignant glioma	0.00189	0.0042	CbGeAlD
Liotrix—Agitation—Carmustine—malignant glioma	0.00187	0.0077	CcSEcCtD
Liotrix—Vision blurred—Temozolomide—malignant glioma	0.00186	0.00764	CcSEcCtD
Liotrix—SLC22A8—central nervous system—malignant glioma	0.00185	0.0041	CbGeAlD
Liotrix—Tremor—Temozolomide—malignant glioma	0.00185	0.00759	CcSEcCtD
Liotrix—Agitation—Temozolomide—malignant glioma	0.00181	0.00745	CcSEcCtD
Liotrix—Angioedema—Temozolomide—malignant glioma	0.0018	0.0074	CcSEcCtD
Liotrix—Convulsion—Carmustine—malignant glioma	0.00177	0.00726	CcSEcCtD
Liotrix—Hypertension—Carmustine—malignant glioma	0.00176	0.00724	CcSEcCtD
Liotrix—Palpitations—Temozolomide—malignant glioma	0.00174	0.00716	CcSEcCtD
Liotrix—Chest pain—Carmustine—malignant glioma	0.00174	0.00714	CcSEcCtD
Liotrix—Anxiety—Carmustine—malignant glioma	0.00173	0.00711	CcSEcCtD
Liotrix—Convulsion—Temozolomide—malignant glioma	0.00171	0.00702	CcSEcCtD
Liotrix—Hypertension—Temozolomide—malignant glioma	0.0017	0.00699	CcSEcCtD
Liotrix—Confusional state—Carmustine—malignant glioma	0.00168	0.0069	CcSEcCtD
Liotrix—Arthralgia—Temozolomide—malignant glioma	0.00168	0.0069	CcSEcCtD
Liotrix—Anxiety—Temozolomide—malignant glioma	0.00167	0.00687	CcSEcCtD
Liotrix—Oedema—Carmustine—malignant glioma	0.00166	0.00684	CcSEcCtD
Liotrix—Infection—Carmustine—malignant glioma	0.00165	0.0068	CcSEcCtD
Liotrix—Tachycardia—Carmustine—malignant glioma	0.00162	0.00668	CcSEcCtD
Liotrix—Confusional state—Temozolomide—malignant glioma	0.00162	0.00667	CcSEcCtD
Liotrix—Oedema—Temozolomide—malignant glioma	0.00161	0.00661	CcSEcCtD
Liotrix—Anaphylactic shock—Temozolomide—malignant glioma	0.00161	0.00661	CcSEcCtD
Liotrix—Infection—Temozolomide—malignant glioma	0.0016	0.00657	CcSEcCtD
Liotrix—Anorexia—Carmustine—malignant glioma	0.00159	0.00652	CcSEcCtD
Liotrix—Hypotension—Carmustine—malignant glioma	0.00156	0.00639	CcSEcCtD
Liotrix—Hyperhidrosis—Temozolomide—malignant glioma	0.00156	0.00639	CcSEcCtD
Liotrix—SLCO1A2—brain—malignant glioma	0.00154	0.00341	CbGeAlD
Liotrix—Anorexia—Temozolomide—malignant glioma	0.00153	0.0063	CcSEcCtD
Liotrix—ALB—brain—malignant glioma	0.00153	0.00339	CbGeAlD
Liotrix—Musculoskeletal discomfort—Carmustine—malignant glioma	0.00152	0.00623	CcSEcCtD
Liotrix—Insomnia—Carmustine—malignant glioma	0.00151	0.00619	CcSEcCtD
Liotrix—Paraesthesia—Carmustine—malignant glioma	0.00149	0.00614	CcSEcCtD
Liotrix—Dyspnoea—Carmustine—malignant glioma	0.00148	0.0061	CcSEcCtD
Liotrix—SLC22A8—brain—malignant glioma	0.00147	0.00326	CbGeAlD
Liotrix—Musculoskeletal discomfort—Temozolomide—malignant glioma	0.00147	0.00602	CcSEcCtD
Liotrix—Insomnia—Temozolomide—malignant glioma	0.00145	0.00598	CcSEcCtD
Liotrix—Decreased appetite—Carmustine—malignant glioma	0.00145	0.00595	CcSEcCtD
Liotrix—Paraesthesia—Temozolomide—malignant glioma	0.00144	0.00594	CcSEcCtD
Liotrix—Dyspnoea—Temozolomide—malignant glioma	0.00143	0.0059	CcSEcCtD
Liotrix—Constipation—Carmustine—malignant glioma	0.00142	0.00585	CcSEcCtD
Liotrix—ABCB1—embryo—malignant glioma	0.0014	0.00311	CbGeAlD
Liotrix—Decreased appetite—Temozolomide—malignant glioma	0.0014	0.00575	CcSEcCtD
Liotrix—Fatigue—Temozolomide—malignant glioma	0.00139	0.0057	CcSEcCtD
Liotrix—Constipation—Temozolomide—malignant glioma	0.00138	0.00565	CcSEcCtD
Liotrix—Feeling abnormal—Carmustine—malignant glioma	0.00137	0.00564	CcSEcCtD
Liotrix—Gastrointestinal pain—Carmustine—malignant glioma	0.00136	0.0056	CcSEcCtD
Liotrix—Feeling abnormal—Temozolomide—malignant glioma	0.00133	0.00545	CcSEcCtD
Liotrix—Abdominal pain—Carmustine—malignant glioma	0.00132	0.00541	CcSEcCtD
Liotrix—Body temperature increased—Carmustine—malignant glioma	0.00132	0.00541	CcSEcCtD
Liotrix—Gastrointestinal pain—Temozolomide—malignant glioma	0.00132	0.00541	CcSEcCtD
Liotrix—Urticaria—Temozolomide—malignant glioma	0.00128	0.00525	CcSEcCtD
Liotrix—Body temperature increased—Temozolomide—malignant glioma	0.00127	0.00523	CcSEcCtD
Liotrix—Abdominal pain—Temozolomide—malignant glioma	0.00127	0.00523	CcSEcCtD
Liotrix—ABCB1—retina—malignant glioma	0.00124	0.00275	CbGeAlD
Liotrix—Hypersensitivity—Carmustine—malignant glioma	0.00123	0.00504	CcSEcCtD
Liotrix—Asthenia—Carmustine—malignant glioma	0.00119	0.00491	CcSEcCtD
Liotrix—Hypersensitivity—Temozolomide—malignant glioma	0.00119	0.00487	CcSEcCtD
Liotrix—Asthenia—Temozolomide—malignant glioma	0.00115	0.00474	CcSEcCtD
Liotrix—ABCB1—telencephalon—malignant glioma	0.00114	0.00253	CbGeAlD
Liotrix—Diarrhoea—Carmustine—malignant glioma	0.00114	0.00468	CcSEcCtD
Liotrix—Pruritus—Temozolomide—malignant glioma	0.00114	0.00468	CcSEcCtD
Liotrix—Dizziness—Carmustine—malignant glioma	0.0011	0.00452	CcSEcCtD
Liotrix—Diarrhoea—Temozolomide—malignant glioma	0.0011	0.00452	CcSEcCtD
Liotrix—CYP2C8—brain—malignant glioma	0.00107	0.00238	CbGeAlD
Liotrix—Dizziness—Temozolomide—malignant glioma	0.00106	0.00437	CcSEcCtD
Liotrix—Vomiting—Carmustine—malignant glioma	0.00106	0.00435	CcSEcCtD
Liotrix—Rash—Carmustine—malignant glioma	0.00105	0.00431	CcSEcCtD
Liotrix—Dermatitis—Carmustine—malignant glioma	0.00105	0.00431	CcSEcCtD
Liotrix—Headache—Carmustine—malignant glioma	0.00104	0.00429	CcSEcCtD
Liotrix—Vomiting—Temozolomide—malignant glioma	0.00102	0.0042	CcSEcCtD
Liotrix—Rash—Temozolomide—malignant glioma	0.00101	0.00417	CcSEcCtD
Liotrix—Dermatitis—Temozolomide—malignant glioma	0.00101	0.00417	CcSEcCtD
Liotrix—Headache—Temozolomide—malignant glioma	0.00101	0.00414	CcSEcCtD
Liotrix—Nausea—Carmustine—malignant glioma	0.000989	0.00406	CcSEcCtD
Liotrix—Nausea—Temozolomide—malignant glioma	0.000956	0.00393	CcSEcCtD
Liotrix—ABCB1—medulla oblongata—malignant glioma	0.000897	0.00199	CbGeAlD
Liotrix—ABCB1—midbrain—malignant glioma	0.00082	0.00182	CbGeAlD
Liotrix—ABCB1—spinal cord—malignant glioma	0.0008	0.00177	CbGeAlD
Liotrix—ABCB1—central nervous system—malignant glioma	0.000649	0.00144	CbGeAlD
Liotrix—ABCB1—cerebellum—malignant glioma	0.000634	0.00141	CbGeAlD
Liotrix—ABCB1—brain—malignant glioma	0.000515	0.00114	CbGeAlD
Liotrix—SLCO1A2—Metabolism—PTGS1—malignant glioma	8.82e-05	0.000288	CbGpPWpGaD
Liotrix—TTR—Signaling Pathways—FGFR1—malignant glioma	8.82e-05	0.000288	CbGpPWpGaD
Liotrix—SLCO1A2—Metabolism of lipids and lipoproteins—PIK3CD—malignant glioma	8.79e-05	0.000287	CbGpPWpGaD
Liotrix—SLC10A1—Metabolism—PPARG—malignant glioma	8.73e-05	0.000285	CbGpPWpGaD
Liotrix—CYP2C8—Metabolism—BCAN—malignant glioma	8.7e-05	0.000284	CbGpPWpGaD
Liotrix—TTR—Signaling Pathways—HIF1A—malignant glioma	8.69e-05	0.000284	CbGpPWpGaD
Liotrix—ALB—Hemostasis—KNG1—malignant glioma	8.67e-05	0.000283	CbGpPWpGaD
Liotrix—ALB—Metabolism—BCAN—malignant glioma	8.65e-05	0.000283	CbGpPWpGaD
Liotrix—ABCB1—Integrated Pancreatic Cancer Pathway—FGF2—malignant glioma	8.63e-05	0.000282	CbGpPWpGaD
Liotrix—TTR—Disease—MDM2—malignant glioma	8.61e-05	0.000281	CbGpPWpGaD
Liotrix—TTR—Disease—RAF1—malignant glioma	8.58e-05	0.00028	CbGpPWpGaD
Liotrix—SLCO1B1—Metabolism of lipids and lipoproteins—PIK3CG—malignant glioma	8.55e-05	0.000279	CbGpPWpGaD
Liotrix—ALB—Hemostasis—IFNA2—malignant glioma	8.5e-05	0.000278	CbGpPWpGaD
Liotrix—TTR—Disease—ERBB2—malignant glioma	8.48e-05	0.000277	CbGpPWpGaD
Liotrix—ALB—Transmembrane transport of small molecules—SLC5A5—malignant glioma	8.45e-05	0.000276	CbGpPWpGaD
Liotrix—SLCO1B3—Metabolism of lipids and lipoproteins—PTEN—malignant glioma	8.43e-05	0.000275	CbGpPWpGaD
Liotrix—SLC22A8—Transmembrane transport of small molecules—RAF1—malignant glioma	8.4e-05	0.000274	CbGpPWpGaD
Liotrix—TTR—Signaling Pathways—CAV1—malignant glioma	8.4e-05	0.000274	CbGpPWpGaD
Liotrix—TTR—Disease—PIK3CB—malignant glioma	8.37e-05	0.000274	CbGpPWpGaD
Liotrix—TTR—Signaling Pathways—KDR—malignant glioma	8.31e-05	0.000271	CbGpPWpGaD
Liotrix—SLCO1B3—Metabolism—GSTP1—malignant glioma	8.3e-05	0.000271	CbGpPWpGaD
Liotrix—TTR—Disease—PTGS2—malignant glioma	8.3e-05	0.000271	CbGpPWpGaD
Liotrix—SLCO1B1—Metabolism of lipids and lipoproteins—PPARG—malignant glioma	8.25e-05	0.00027	CbGpPWpGaD
Liotrix—SLCO1A2—Metabolism—BCHE—malignant glioma	8.2e-05	0.000268	CbGpPWpGaD
Liotrix—ABCB1—Integrated Pancreatic Cancer Pathway—BCL2—malignant glioma	8.19e-05	0.000268	CbGpPWpGaD
Liotrix—ALB—Platelet activation, signaling and aggregation—RAF1—malignant glioma	8.17e-05	0.000267	CbGpPWpGaD
Liotrix—SLCO1A2—Metabolism—SLC5A5—malignant glioma	8.1e-05	0.000265	CbGpPWpGaD
Liotrix—SLCO1B3—Metabolism—CAT—malignant glioma	8.08e-05	0.000264	CbGpPWpGaD
Liotrix—ABCB1—Integrated Pancreatic Cancer Pathway—MDM2—malignant glioma	8.07e-05	0.000264	CbGpPWpGaD
Liotrix—ABCB1—Metabolism—ASMT—malignant glioma	8.07e-05	0.000263	CbGpPWpGaD
Liotrix—ABCB1—Transmembrane transport of small molecules—TFRC—malignant glioma	8.06e-05	0.000263	CbGpPWpGaD
Liotrix—ALB—Hemostasis—SOD1—malignant glioma	8.06e-05	0.000263	CbGpPWpGaD
Liotrix—SLCO1B1—Metabolism—GSTT1—malignant glioma	8.05e-05	0.000263	CbGpPWpGaD
Liotrix—ABCB1—Integrated Pancreatic Cancer Pathway—RAF1—malignant glioma	8.04e-05	0.000263	CbGpPWpGaD
Liotrix—ALB—Transmembrane transport of small molecules—SLC6A3—malignant glioma	8.04e-05	0.000263	CbGpPWpGaD
Liotrix—TTR—Signaling Pathways—F2—malignant glioma	8e-05	0.000261	CbGpPWpGaD
Liotrix—TTR—Signaling Pathways—FN1—malignant glioma	8e-05	0.000261	CbGpPWpGaD
Liotrix—ALB—Platelet activation, signaling and aggregation—PIK3CB—malignant glioma	7.98e-05	0.000261	CbGpPWpGaD
Liotrix—ABCB1—Integrated Pancreatic Cancer Pathway—ERBB2—malignant glioma	7.96e-05	0.00026	CbGpPWpGaD
Liotrix—SLC10A1—Metabolism—PIK3CD—malignant glioma	7.95e-05	0.00026	CbGpPWpGaD
Liotrix—TTR—Signaling Pathways—BAD—malignant glioma	7.9e-05	0.000258	CbGpPWpGaD
Liotrix—TTR—Signaling Pathways—NOTCH1—malignant glioma	7.82e-05	0.000256	CbGpPWpGaD
Liotrix—ABCB1—Integrated Pancreatic Cancer Pathway—PTGS2—malignant glioma	7.78e-05	0.000254	CbGpPWpGaD
Liotrix—TTR—Signaling Pathways—CD80—malignant glioma	7.67e-05	0.00025	CbGpPWpGaD
Liotrix—SLCO1A2—Metabolism of lipids and lipoproteins—PIK3CB—malignant glioma	7.66e-05	0.00025	CbGpPWpGaD
Liotrix—TTR—Signaling Pathways—APC—malignant glioma	7.65e-05	0.00025	CbGpPWpGaD
Liotrix—TTR—Signaling Pathways—PIK3CG—malignant glioma	7.65e-05	0.00025	CbGpPWpGaD
Liotrix—SLCO1B3—Metabolism—NCOR1—malignant glioma	7.63e-05	0.000249	CbGpPWpGaD
Liotrix—SLCO1A2—Metabolism of lipids and lipoproteins—PTGS2—malignant glioma	7.59e-05	0.000248	CbGpPWpGaD
Liotrix—ABCB1—Metabolism—BCAN—malignant glioma	7.58e-05	0.000248	CbGpPWpGaD
Liotrix—TTR—Signaling Pathways—EGF—malignant glioma	7.56e-05	0.000247	CbGpPWpGaD
Liotrix—SLCO1B1—Metabolism—PTGS1—malignant glioma	7.54e-05	0.000246	CbGpPWpGaD
Liotrix—TTR—Signaling Pathways—PTPN11—malignant glioma	7.52e-05	0.000246	CbGpPWpGaD
Liotrix—SLCO1B1—Metabolism of lipids and lipoproteins—PIK3CD—malignant glioma	7.52e-05	0.000245	CbGpPWpGaD
Liotrix—SLCO1A2—Transmembrane transport of small molecules—RAF1—malignant glioma	7.46e-05	0.000244	CbGpPWpGaD
Liotrix—ABCB1—Transmembrane transport of small molecules—SLC5A5—malignant glioma	7.4e-05	0.000242	CbGpPWpGaD
Liotrix—ALB—Hemostasis—PTK2—malignant glioma	7.4e-05	0.000242	CbGpPWpGaD
Liotrix—ALB—Platelet activation, signaling and aggregation—IL2—malignant glioma	7.32e-05	0.000239	CbGpPWpGaD
Liotrix—TTR—Disease—PTEN—malignant glioma	7.24e-05	0.000236	CbGpPWpGaD
Liotrix—ABCB1—Integrated Pancreatic Cancer Pathway—CASP3—malignant glioma	7.22e-05	0.000236	CbGpPWpGaD
Liotrix—TTR—Signaling Pathways—BRAF—malignant glioma	7.19e-05	0.000235	CbGpPWpGaD
Liotrix—ABCB1—Transmembrane transport of small molecules—SLC6A3—malignant glioma	7.05e-05	0.00023	CbGpPWpGaD
Liotrix—CYP2C8—Metabolism—IDH2—malignant glioma	7.02e-05	0.000229	CbGpPWpGaD
Liotrix—SLCO1B1—Metabolism—BCHE—malignant glioma	7.01e-05	0.000229	CbGpPWpGaD
Liotrix—TTR—Signaling Pathways—AKT2—malignant glioma	7e-05	0.000229	CbGpPWpGaD
Liotrix—ALB—Metabolism—IDH2—malignant glioma	6.98e-05	0.000228	CbGpPWpGaD
Liotrix—SLC10A1—Metabolism—PIK3CB—malignant glioma	6.93e-05	0.000226	CbGpPWpGaD
Liotrix—SLCO1B1—Metabolism—SLC5A5—malignant glioma	6.93e-05	0.000226	CbGpPWpGaD
Liotrix—SLC10A1—Metabolism—PTGS2—malignant glioma	6.87e-05	0.000224	CbGpPWpGaD
Liotrix—ABCB1—Integrated Pancreatic Cancer Pathway—PTEN—malignant glioma	6.79e-05	0.000222	CbGpPWpGaD
Liotrix—TTR—Signaling Pathways—PIK3CD—malignant glioma	6.73e-05	0.00022	CbGpPWpGaD
Liotrix—SLCO1A2—Metabolism of lipids and lipoproteins—PTEN—malignant glioma	6.62e-05	0.000216	CbGpPWpGaD
Liotrix—CYP2C8—Metabolism of lipids and lipoproteins—NCOR1—malignant glioma	6.62e-05	0.000216	CbGpPWpGaD
Liotrix—CYP2C8—Metabolism—CYP2B6—malignant glioma	6.6e-05	0.000215	CbGpPWpGaD
Liotrix—ALB—Metabolism of lipids and lipoproteins—NCOR1—malignant glioma	6.58e-05	0.000215	CbGpPWpGaD
Liotrix—ALB—Metabolism—CYP2B6—malignant glioma	6.56e-05	0.000214	CbGpPWpGaD
Liotrix—SLCO1B1—Metabolism of lipids and lipoproteins—PIK3CB—malignant glioma	6.55e-05	0.000214	CbGpPWpGaD
Liotrix—SLCO1A2—Metabolism—GSTP1—malignant glioma	6.52e-05	0.000213	CbGpPWpGaD
Liotrix—SLCO1B1—Metabolism of lipids and lipoproteins—PTGS2—malignant glioma	6.49e-05	0.000212	CbGpPWpGaD
Liotrix—TTR—Disease—STAT3—malignant glioma	6.47e-05	0.000211	CbGpPWpGaD
Liotrix—TTR—Signaling Pathways—FGF2—malignant glioma	6.44e-05	0.00021	CbGpPWpGaD
Liotrix—SLCO1B1—Transmembrane transport of small molecules—RAF1—malignant glioma	6.38e-05	0.000208	CbGpPWpGaD
Liotrix—SLCO1A2—Metabolism—CAT—malignant glioma	6.35e-05	0.000207	CbGpPWpGaD
Liotrix—THRA—Gene Expression—AKT1—malignant glioma	6.3e-05	0.000206	CbGpPWpGaD
Liotrix—THRB—Gene Expression—AKT1—malignant glioma	6.3e-05	0.000206	CbGpPWpGaD
Liotrix—ALB—Platelet activation, signaling and aggregation—VEGFA—malignant glioma	6.22e-05	0.000203	CbGpPWpGaD
Liotrix—SLCO1B3—Metabolism—CAV1—malignant glioma	6.22e-05	0.000203	CbGpPWpGaD
Liotrix—ALB—Hemostasis—PDGFB—malignant glioma	6.22e-05	0.000203	CbGpPWpGaD
Liotrix—ABCB1—Integrated Pancreatic Cancer Pathway—VEGFA—malignant glioma	6.13e-05	0.0002	CbGpPWpGaD
Liotrix—ABCB1—Metabolism—IDH2—malignant glioma	6.11e-05	0.0002	CbGpPWpGaD
Liotrix—CYP2C8—Metabolism—IDH1—malignant glioma	6.03e-05	0.000197	CbGpPWpGaD
Liotrix—TTR—Signaling Pathways—MDM2—malignant glioma	6.03e-05	0.000197	CbGpPWpGaD
Liotrix—TTR—Disease—MYC—malignant glioma	6.01e-05	0.000196	CbGpPWpGaD
Liotrix—TTR—Signaling Pathways—RAF1—malignant glioma	6.01e-05	0.000196	CbGpPWpGaD
Liotrix—ALB—Metabolism—IDH1—malignant glioma	6e-05	0.000196	CbGpPWpGaD
Liotrix—SLCO1A2—Metabolism—NCOR1—malignant glioma	6e-05	0.000196	CbGpPWpGaD
Liotrix—SLC10A1—Metabolism—PTEN—malignant glioma	5.99e-05	0.000196	CbGpPWpGaD
Liotrix—SLCO1B3—Metabolism of lipids and lipoproteins—PIK3CA—malignant glioma	5.94e-05	0.000194	CbGpPWpGaD
Liotrix—TTR—Signaling Pathways—ERBB2—malignant glioma	5.94e-05	0.000194	CbGpPWpGaD
Liotrix—ALB—Hemostasis—CAV1—malignant glioma	5.89e-05	0.000192	CbGpPWpGaD
Liotrix—TTR—Disease—EGFR—malignant glioma	5.88e-05	0.000192	CbGpPWpGaD
Liotrix—TTR—Signaling Pathways—PIK3CB—malignant glioma	5.86e-05	0.000192	CbGpPWpGaD
Liotrix—CYP2C8—Metabolism—SPHK1—malignant glioma	5.84e-05	0.000191	CbGpPWpGaD
Liotrix—ALB—Metabolism—SPHK1—malignant glioma	5.8e-05	0.00019	CbGpPWpGaD
Liotrix—ABCB1—Metabolism—CYP2B6—malignant glioma	5.75e-05	0.000188	CbGpPWpGaD
Liotrix—CYP2C8—Metabolism—CYP2C18—malignant glioma	5.72e-05	0.000187	CbGpPWpGaD
Liotrix—ALB—Metabolism—CYP2C18—malignant glioma	5.69e-05	0.000186	CbGpPWpGaD
Liotrix—SLCO1B3—Metabolism—PIK3CG—malignant glioma	5.67e-05	0.000185	CbGpPWpGaD
Liotrix—SLCO1B1—Metabolism of lipids and lipoproteins—PTEN—malignant glioma	5.66e-05	0.000185	CbGpPWpGaD
Liotrix—ABCB1—Integrated Pancreatic Cancer Pathway—MYC—malignant glioma	5.64e-05	0.000184	CbGpPWpGaD
Liotrix—TTR—Signaling Pathways—CXCL8—malignant glioma	5.63e-05	0.000184	CbGpPWpGaD
Liotrix—ALB—Hemostasis—FN1—malignant glioma	5.61e-05	0.000183	CbGpPWpGaD
Liotrix—ALB—Hemostasis—F2—malignant glioma	5.61e-05	0.000183	CbGpPWpGaD
Liotrix—SLCO1B1—Metabolism—GSTP1—malignant glioma	5.58e-05	0.000182	CbGpPWpGaD
Liotrix—TTR—Disease—KRAS—malignant glioma	5.56e-05	0.000181	CbGpPWpGaD
Liotrix—ABCB1—Integrated Pancreatic Cancer Pathway—EGFR—malignant glioma	5.52e-05	0.00018	CbGpPWpGaD
Liotrix—SLCO1B3—Metabolism—PPARG—malignant glioma	5.47e-05	0.000179	CbGpPWpGaD
Liotrix—SLCO1B1—Metabolism—CAT—malignant glioma	5.43e-05	0.000177	CbGpPWpGaD
Liotrix—CYP2C8—Metabolism of lipids and lipoproteins—CAV1—malignant glioma	5.39e-05	0.000176	CbGpPWpGaD
Liotrix—TTR—Signaling Pathways—CASP3—malignant glioma	5.39e-05	0.000176	CbGpPWpGaD
Liotrix—TTR—Signaling Pathways—IL2—malignant glioma	5.38e-05	0.000176	CbGpPWpGaD
Liotrix—ALB—Hemostasis—PIK3CG—malignant glioma	5.37e-05	0.000175	CbGpPWpGaD
Liotrix—ALB—Metabolism of lipids and lipoproteins—CAV1—malignant glioma	5.36e-05	0.000175	CbGpPWpGaD
Liotrix—ALB—Hemostasis—EGF—malignant glioma	5.3e-05	0.000173	CbGpPWpGaD
Liotrix—ALB—Hemostasis—PTPN11—malignant glioma	5.27e-05	0.000172	CbGpPWpGaD
Liotrix—ABCB1—Metabolism—IDH1—malignant glioma	5.26e-05	0.000172	CbGpPWpGaD
Liotrix—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—malignant glioma	5.25e-05	0.000172	CbGpPWpGaD
Liotrix—ABCB1—Integrated Pancreatic Cancer Pathway—KRAS—malignant glioma	5.21e-05	0.00017	CbGpPWpGaD
Liotrix—SLCO1B1—Metabolism—NCOR1—malignant glioma	5.13e-05	0.000167	CbGpPWpGaD
Liotrix—TTR—Disease—PIK3CA—malignant glioma	5.1e-05	0.000167	CbGpPWpGaD
Liotrix—TTR—Signaling Pathways—MMP9—malignant glioma	5.1e-05	0.000166	CbGpPWpGaD
Liotrix—ABCB1—Metabolism—SPHK1—malignant glioma	5.09e-05	0.000166	CbGpPWpGaD
Liotrix—TTR—Signaling Pathways—PTEN—malignant glioma	5.07e-05	0.000166	CbGpPWpGaD
Liotrix—ABCB1—Metabolism—CYP2C18—malignant glioma	4.98e-05	0.000163	CbGpPWpGaD
Liotrix—SLCO1B3—Metabolism—PIK3CD—malignant glioma	4.98e-05	0.000163	CbGpPWpGaD
Liotrix—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CG—malignant glioma	4.91e-05	0.00016	CbGpPWpGaD
Liotrix—ALB—Hemostasis—AKT2—malignant glioma	4.91e-05	0.00016	CbGpPWpGaD
Liotrix—SLCO1A2—Metabolism—CAV1—malignant glioma	4.89e-05	0.00016	CbGpPWpGaD
Liotrix—ALB—Metabolism of lipids and lipoproteins—PIK3CG—malignant glioma	4.88e-05	0.00016	CbGpPWpGaD
Liotrix—ALB—Platelet activation, signaling and aggregation—PIK3CA—malignant glioma	4.86e-05	0.000159	CbGpPWpGaD
Liotrix—ABCB1—Integrated Pancreatic Cancer Pathway—PIK3CA—malignant glioma	4.79e-05	0.000156	CbGpPWpGaD
Liotrix—CYP2C8—Metabolism of lipids and lipoproteins—PPARG—malignant glioma	4.74e-05	0.000155	CbGpPWpGaD
Liotrix—ALB—Hemostasis—PIK3CD—malignant glioma	4.72e-05	0.000154	CbGpPWpGaD
Liotrix—ALB—Metabolism of lipids and lipoproteins—PPARG—malignant glioma	4.71e-05	0.000154	CbGpPWpGaD
Liotrix—SLCO1A2—Metabolism of lipids and lipoproteins—PIK3CA—malignant glioma	4.67e-05	0.000153	CbGpPWpGaD
Liotrix—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—malignant glioma	4.63e-05	0.000151	CbGpPWpGaD
Liotrix—CYP2C8—Metabolism—GSTT1—malignant glioma	4.63e-05	0.000151	CbGpPWpGaD
Liotrix—ALB—Metabolism—GSTT1—malignant glioma	4.6e-05	0.00015	CbGpPWpGaD
Liotrix—TTR—Signaling Pathways—VEGFA—malignant glioma	4.58e-05	0.000149	CbGpPWpGaD
Liotrix—TTR—Signaling Pathways—STAT3—malignant glioma	4.53e-05	0.000148	CbGpPWpGaD
Liotrix—SLCO1A2—Metabolism—PIK3CG—malignant glioma	4.45e-05	0.000145	CbGpPWpGaD
Liotrix—SLCO1B3—Metabolism—PIK3CB—malignant glioma	4.34e-05	0.000142	CbGpPWpGaD
Liotrix—CYP2C8—Metabolism—PTGS1—malignant glioma	4.33e-05	0.000142	CbGpPWpGaD
Liotrix—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CD—malignant glioma	4.32e-05	0.000141	CbGpPWpGaD
Liotrix—ALB—Metabolism—PTGS1—malignant glioma	4.31e-05	0.000141	CbGpPWpGaD
Liotrix—SLCO1B3—Metabolism—PTGS2—malignant glioma	4.3e-05	0.000141	CbGpPWpGaD
Liotrix—SLCO1A2—Metabolism—PPARG—malignant glioma	4.3e-05	0.00014	CbGpPWpGaD
Liotrix—ALB—Metabolism of lipids and lipoproteins—PIK3CD—malignant glioma	4.29e-05	0.00014	CbGpPWpGaD
Liotrix—SLC10A1—Metabolism—PIK3CA—malignant glioma	4.23e-05	0.000138	CbGpPWpGaD
Liotrix—ALB—Hemostasis—RAF1—malignant glioma	4.21e-05	0.000138	CbGpPWpGaD
Liotrix—TTR—Signaling Pathways—MYC—malignant glioma	4.21e-05	0.000138	CbGpPWpGaD
Liotrix—SLCO1B1—Metabolism—CAV1—malignant glioma	4.18e-05	0.000137	CbGpPWpGaD
Liotrix—TTR—Disease—AKT1—malignant glioma	4.17e-05	0.000136	CbGpPWpGaD
Liotrix—TTR—Signaling Pathways—EGFR—malignant glioma	4.12e-05	0.000135	CbGpPWpGaD
Liotrix—ALB—Hemostasis—PIK3CB—malignant glioma	4.11e-05	0.000134	CbGpPWpGaD
Liotrix—ABCB1—Metabolism—GSTT1—malignant glioma	4.03e-05	0.000132	CbGpPWpGaD
Liotrix—CYP2C8—Metabolism—BCHE—malignant glioma	4.03e-05	0.000132	CbGpPWpGaD
Liotrix—ALB—Metabolism—BCHE—malignant glioma	4.01e-05	0.000131	CbGpPWpGaD
Liotrix—SLCO1B1—Metabolism of lipids and lipoproteins—PIK3CA—malignant glioma	3.99e-05	0.00013	CbGpPWpGaD
Liotrix—CYP2C8—Metabolism—SLC5A5—malignant glioma	3.98e-05	0.00013	CbGpPWpGaD
Liotrix—ALB—Platelet activation, signaling and aggregation—AKT1—malignant glioma	3.97e-05	0.00013	CbGpPWpGaD
Liotrix—ALB—Metabolism—SLC5A5—malignant glioma	3.96e-05	0.000129	CbGpPWpGaD
Liotrix—SLCO1A2—Metabolism—PIK3CD—malignant glioma	3.91e-05	0.000128	CbGpPWpGaD
Liotrix—ABCB1—Integrated Pancreatic Cancer Pathway—AKT1—malignant glioma	3.91e-05	0.000128	CbGpPWpGaD
Liotrix—TTR—Signaling Pathways—KRAS—malignant glioma	3.89e-05	0.000127	CbGpPWpGaD
Liotrix—SLCO1B1—Metabolism—PIK3CG—malignant glioma	3.81e-05	0.000124	CbGpPWpGaD
Liotrix—ABCB1—Metabolism—PTGS1—malignant glioma	3.78e-05	0.000123	CbGpPWpGaD
Liotrix—ALB—Hemostasis—IL2—malignant glioma	3.78e-05	0.000123	CbGpPWpGaD
Liotrix—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CB—malignant glioma	3.76e-05	0.000123	CbGpPWpGaD
Liotrix—SLCO1B3—Metabolism—PTEN—malignant glioma	3.75e-05	0.000123	CbGpPWpGaD
Liotrix—ALB—Metabolism of lipids and lipoproteins—PIK3CB—malignant glioma	3.74e-05	0.000122	CbGpPWpGaD
Liotrix—CYP2C8—Metabolism of lipids and lipoproteins—PTGS2—malignant glioma	3.73e-05	0.000122	CbGpPWpGaD
Liotrix—ALB—Metabolism of lipids and lipoproteins—PTGS2—malignant glioma	3.71e-05	0.000121	CbGpPWpGaD
Liotrix—SLCO1B1—Metabolism—PPARG—malignant glioma	3.67e-05	0.00012	CbGpPWpGaD
Liotrix—ALB—Transmembrane transport of small molecules—RAF1—malignant glioma	3.65e-05	0.000119	CbGpPWpGaD
Liotrix—TTR—Signaling Pathways—PIK3CA—malignant glioma	3.57e-05	0.000117	CbGpPWpGaD
Liotrix—ABCB1—Metabolism—BCHE—malignant glioma	3.51e-05	0.000115	CbGpPWpGaD
Liotrix—ABCB1—Metabolism—SLC5A5—malignant glioma	3.47e-05	0.000113	CbGpPWpGaD
Liotrix—TTR—Signaling Pathways—TP53—malignant glioma	3.46e-05	0.000113	CbGpPWpGaD
Liotrix—SLC10A1—Metabolism—AKT1—malignant glioma	3.45e-05	0.000113	CbGpPWpGaD
Liotrix—SLCO1A2—Metabolism—PIK3CB—malignant glioma	3.41e-05	0.000111	CbGpPWpGaD
Liotrix—SLCO1A2—Metabolism—PTGS2—malignant glioma	3.38e-05	0.00011	CbGpPWpGaD
Liotrix—SLCO1B1—Metabolism—PIK3CD—malignant glioma	3.35e-05	0.000109	CbGpPWpGaD
Liotrix—CYP2C8—Metabolism of lipids and lipoproteins—PTEN—malignant glioma	3.25e-05	0.000106	CbGpPWpGaD
Liotrix—ALB—Metabolism of lipids and lipoproteins—PTEN—malignant glioma	3.23e-05	0.000106	CbGpPWpGaD
Liotrix—ALB—Hemostasis—VEGFA—malignant glioma	3.21e-05	0.000105	CbGpPWpGaD
Liotrix—CYP2C8—Metabolism—GSTP1—malignant glioma	3.21e-05	0.000105	CbGpPWpGaD
Liotrix—ABCB1—Transmembrane transport of small molecules—RAF1—malignant glioma	3.19e-05	0.000104	CbGpPWpGaD
Liotrix—ALB—Metabolism—GSTP1—malignant glioma	3.19e-05	0.000104	CbGpPWpGaD
Liotrix—CYP2C8—Metabolism—CAT—malignant glioma	3.12e-05	0.000102	CbGpPWpGaD
Liotrix—ALB—Metabolism—CAT—malignant glioma	3.1e-05	0.000101	CbGpPWpGaD
Liotrix—SLCO1A2—Metabolism—PTEN—malignant glioma	2.95e-05	9.63e-05	CbGpPWpGaD
Liotrix—CYP2C8—Metabolism—NCOR1—malignant glioma	2.95e-05	9.62e-05	CbGpPWpGaD
Liotrix—ALB—Metabolism—NCOR1—malignant glioma	2.93e-05	9.57e-05	CbGpPWpGaD
Liotrix—TTR—Signaling Pathways—AKT1—malignant glioma	2.92e-05	9.54e-05	CbGpPWpGaD
Liotrix—SLCO1B1—Metabolism—PIK3CB—malignant glioma	2.92e-05	9.53e-05	CbGpPWpGaD
Liotrix—SLCO1B1—Metabolism—PTGS2—malignant glioma	2.89e-05	9.44e-05	CbGpPWpGaD
Liotrix—ABCB1—Metabolism—GSTP1—malignant glioma	2.79e-05	9.12e-05	CbGpPWpGaD
Liotrix—ALB—Hemostasis—KRAS—malignant glioma	2.73e-05	8.91e-05	CbGpPWpGaD
Liotrix—ABCB1—Metabolism—CAT—malignant glioma	2.72e-05	8.88e-05	CbGpPWpGaD
Liotrix—SLCO1B3—Metabolism—PIK3CA—malignant glioma	2.65e-05	8.65e-05	CbGpPWpGaD
Liotrix—ABCB1—Metabolism—NCOR1—malignant glioma	2.57e-05	8.38e-05	CbGpPWpGaD
Liotrix—SLCO1B1—Metabolism—PTEN—malignant glioma	2.52e-05	8.23e-05	CbGpPWpGaD
Liotrix—ALB—Hemostasis—PIK3CA—malignant glioma	2.51e-05	8.19e-05	CbGpPWpGaD
Liotrix—ALB—Hemostasis—TP53—malignant glioma	2.42e-05	7.92e-05	CbGpPWpGaD
Liotrix—CYP2C8—Metabolism—CAV1—malignant glioma	2.4e-05	7.85e-05	CbGpPWpGaD
Liotrix—ALB—Metabolism—CAV1—malignant glioma	2.39e-05	7.8e-05	CbGpPWpGaD
Liotrix—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CA—malignant glioma	2.29e-05	7.5e-05	CbGpPWpGaD
Liotrix—ALB—Metabolism of lipids and lipoproteins—PIK3CA—malignant glioma	2.28e-05	7.45e-05	CbGpPWpGaD
Liotrix—CYP2C8—Metabolism—PIK3CG—malignant glioma	2.19e-05	7.15e-05	CbGpPWpGaD
Liotrix—ALB—Metabolism—PIK3CG—malignant glioma	2.18e-05	7.11e-05	CbGpPWpGaD
Liotrix—SLCO1B3—Metabolism—AKT1—malignant glioma	2.16e-05	7.06e-05	CbGpPWpGaD
Liotrix—CYP2C8—Metabolism—PPARG—malignant glioma	2.11e-05	6.9e-05	CbGpPWpGaD
Liotrix—ALB—Metabolism—PPARG—malignant glioma	2.1e-05	6.86e-05	CbGpPWpGaD
Liotrix—ABCB1—Metabolism—CAV1—malignant glioma	2.09e-05	6.84e-05	CbGpPWpGaD
Liotrix—SLCO1A2—Metabolism—PIK3CA—malignant glioma	2.08e-05	6.79e-05	CbGpPWpGaD
Liotrix—ALB—Hemostasis—AKT1—malignant glioma	2.05e-05	6.69e-05	CbGpPWpGaD
Liotrix—CYP2C8—Metabolism—PIK3CD—malignant glioma	1.92e-05	6.28e-05	CbGpPWpGaD
Liotrix—ALB—Metabolism—PIK3CD—malignant glioma	1.91e-05	6.25e-05	CbGpPWpGaD
Liotrix—ABCB1—Metabolism—PIK3CG—malignant glioma	1.91e-05	6.23e-05	CbGpPWpGaD
Liotrix—ABCB1—Metabolism—PPARG—malignant glioma	1.84e-05	6.01e-05	CbGpPWpGaD
Liotrix—SLCO1B1—Metabolism—PIK3CA—malignant glioma	1.78e-05	5.81e-05	CbGpPWpGaD
Liotrix—SLCO1A2—Metabolism—AKT1—malignant glioma	1.7e-05	5.55e-05	CbGpPWpGaD
Liotrix—CYP2C8—Metabolism—PIK3CB—malignant glioma	1.68e-05	5.48e-05	CbGpPWpGaD
Liotrix—ABCB1—Metabolism—PIK3CD—malignant glioma	1.68e-05	5.47e-05	CbGpPWpGaD
Liotrix—ALB—Metabolism—PIK3CB—malignant glioma	1.67e-05	5.44e-05	CbGpPWpGaD
Liotrix—CYP2C8—Metabolism—PTGS2—malignant glioma	1.66e-05	5.43e-05	CbGpPWpGaD
Liotrix—ALB—Metabolism—PTGS2—malignant glioma	1.65e-05	5.4e-05	CbGpPWpGaD
Liotrix—ABCB1—Metabolism—PIK3CB—malignant glioma	1.46e-05	4.77e-05	CbGpPWpGaD
Liotrix—SLCO1B1—Metabolism—AKT1—malignant glioma	1.45e-05	4.75e-05	CbGpPWpGaD
Liotrix—CYP2C8—Metabolism—PTEN—malignant glioma	1.45e-05	4.73e-05	CbGpPWpGaD
Liotrix—ABCB1—Metabolism—PTGS2—malignant glioma	1.45e-05	4.73e-05	CbGpPWpGaD
Liotrix—ALB—Metabolism—PTEN—malignant glioma	1.44e-05	4.7e-05	CbGpPWpGaD
Liotrix—ABCB1—Metabolism—PTEN—malignant glioma	1.26e-05	4.12e-05	CbGpPWpGaD
Liotrix—CYP2C8—Metabolism—PIK3CA—malignant glioma	1.02e-05	3.34e-05	CbGpPWpGaD
Liotrix—ALB—Metabolism—PIK3CA—malignant glioma	1.02e-05	3.32e-05	CbGpPWpGaD
Liotrix—ABCB1—Metabolism—PIK3CA—malignant glioma	8.9e-06	2.91e-05	CbGpPWpGaD
Liotrix—CYP2C8—Metabolism—AKT1—malignant glioma	8.35e-06	2.73e-05	CbGpPWpGaD
Liotrix—ALB—Metabolism—AKT1—malignant glioma	8.3e-06	2.71e-05	CbGpPWpGaD
Liotrix—ABCB1—Metabolism—AKT1—malignant glioma	7.27e-06	2.38e-05	CbGpPWpGaD
